ADMA Biologics Statistics
NASDAQ: ADMAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
10.14-0.04 (-0.39%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ADMA Biologics by the numbers
ADMA Biologics has a market capitalization of $2.27 billion based on 223.98M shares outstanding. Its trailing P/E ratio is 14.5, and its forward P/E is 10.7. The stock trades 7.0% above its 50-day average and 13.0% below its 200-day average.
Average daily trading volume is 2.62M shares, or about $26.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ADMA valuation vs. peer median
| Metric | ADMA | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.27B | $2.09B | +9% |
| Forward P/E | 10.7 | 28.1 | -62% |
| Avg. volume | 2.62M | 1.91M | +37% |
Peer median across 8 companies: RXRX, BCRX, ALVO, VCEL, BEAM, VIR, NVAX, MESO.
Valuation
- Market cap
- $2.27B
- P/E (TTM)
- 14.49
- Forward P/E
- 10.75
- EPS (TTM)
- $0.70
- Shares outstanding
- 223.98M
Price and trading
- Previous close
- 10.18
- Open
- 10.15
- Day range
- 10.07 – 10.31
- 52-week range
- 7.21 – 20.46
- 52-week change
- -27.52%
- Beta
- —
- Volume
- 3.05M
- Average volume
- 2.62M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 2.27B
- Pe
- 14.49
- Forward Pe
- 10.75
- Eps
- 0.70
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 20.46
- Week52 Low
- 7.21
- Avg Volume
- 2.62M
- Shares Outstanding
- 223.98M
- Ma50
- 9.48
- Ma200
- 11.66
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -50.44%
- Pct From52w Low
- 40.64%